NEW YORK, January 30, 2017 /PRNewswire/ --
The Business Services industry is a highly fragmented space that providescompanies with business-related services such as marketing, advertising, consulting, legal, and logistics. The production in this industry is divided among many different companies, so no single firm has a large enough share of the market to be able
Parsippany, New Jersey headquartered Interpace Diagnostics Group Inc.'s stock recorded a trading volume of 194,112 shares last Friday, and finished the trading session 2.68% lower at $4.35. The Company's shares have surged 210.71% over the previous three months. The stock is trading above its 200-day moving average by 26.92%. Furthermore, shares of Interpace Diagnostics Group, which develops and commercializes molecular diagnostic tests for physicians and patients to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers in the US, have a Relative Strength Index (RSI) of 46.31.
On January 24th, 2017, Interpace Diagnostics announced its most recent entrée into expanding its commercial foot print internationally as a result of the adoption of the ThyGenX test by Dr. Richard Payne of Montreal, Quebec. This is the Company's initial step in launching its Thyroid products in Canada and, if successful, plans are already in place to expand in to other Provinces and work with the Canadian Health Ministry to secure coverage of both ThyGenX®, the Company's oncogene panel assay, and ThyraMir®, the Company's micro- RNA based gene expression classifier. Access our complete research report on IDXG for free at:
On Friday, Cincinnati, Ohio headquartered Convergys Corp.'s stock ended the session 0.08% higher at $25.49. A total volume of 299,514 shares was traded. The Company's shares have gained 2.78% in the last one month and 3.79% on an YTD basis. The stock is trading 1.16% above its 50-day moving average. Moreover, shares of Convergys, which provides customer management services to communications and media, technology, financial services, retail, and healthcare industries in North America and internationally, have an RSI of 49.96.
As per a SEC filing dated January 17th, 2017, Convergys entered into a Credit Agreement on January 11th, 2017 with the lenders identified therein and Citibank, N.A., as Administrative Agent. The New Credit Agreement consists of a $215 million unsecured term loan facility and a $300 million unsecured revolving credit facility. The Term Loan Facility matures on March 03rd, 2019 and the Revolving Credit Facility matures on January 11th, 2022. The New Credit Agreement replaces the Company's existing credit agreement, which consisted of a $300 million unsecured revolving credit facility and a $350 million term loan facility that had approximately $215 million of term loan borrowings remaining outstanding as of September 30th, 2016. The Existing Credit Agreement was scheduled to mature in March 2019. The complimentary research report on CVG can be downloaded at:
Irving, Texas headquartered HMS Holdings Corp.'s stock ended the day 0.11% higher at $18.05 with a total trading volume of 214,399 shares. The Company's shares are trading 1.07% below their 50-day moving average. Shares of the Company, which through its subsidiaries, operates in the healthcare insurance benefit cost containment market in the US, have an RSI of 46.00. Register for free on Stock-Callers.com and get access to the latest PDF format report on HMSY at:
Shares in Norwalk, Connecticut headquartered The Priceline Group Inc. recorded a trading volume of 428,182 shares, and ended Friday's session 1.36% higher at $1,602.92. The stock has gained 7.33% in the last month, 9.10% over the previous three months, and 9.34% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 5.67% and 13.61%, respectively. Furthermore, shares of Priceline Group, which provides online travel and restaurant reservation and related services, have an RSI of 75.40.
On January 18th, 2017, research firm Miller Tabak initiated a 'Buy' rating on the Company's stock, with a target price of $1750 per share.
On January 20th, 2017, Ingenico ePayments, the online and mobile commerce division of Ingenico Group, announced that it has signed an agreement to provide global payment processing and conversion optimization services to Booking.com, the part of The Priceline Group. With Ingenico`s global footprint and large portfolio of international cards and alternative payment products, Booking.com is able to increase the conversion rate of visits into online payments made through its platform. Download your free research report on PCLN at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Malaria is a dangerous disease with lethal consequences that requires protective measures for ...
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...View All